59 / 74 · 0:56 · Original AXON film
Kisspeptin
The burned-in captions and transcript carry the scientific claims and their limitations. The visuals are conceptual illustrations, not validated molecular models or experimental images. The video has no voice or audio. The full explanation is visible on screen; optional accessible captions are available in the player.
Read every result in its study context. A cell experiment, animal model, exploratory analysis and controlled human trial answer different questions.
Prepared 05 November 2026. Regulatory status is jurisdiction- and date-specific. No claim of specialist review or exhaustive evidence coverage.
Transcript
Identify the form: kisspeptin-54
Kisspeptin belongs to a family of reproductive signaling peptides. A study using kisspeptin-54 cannot automatically describe every fragment sold under the broader name. [1]
HUMAN TRIAL | 32 completed both visits
In a randomized crossover trial, 32 women with hypoactive sexual desire disorder completed both experimental visits. Researchers measured brain responses to sexual and attraction stimuli. [1]
Brain activity is a specific endpoint
Kisspeptin changed activity in selected brain regions. These short-term imaging findings help investigate biology, but they do not establish durable improvement in daily life. [1]
Long-term outcomes need testing
The tested population, molecular form and research setting matter. Longer studies must evaluate patient-important benefits and safety before broader treatment conclusions are justified. [1]
Sources and context
These linked sources support the evidence distinctions in this short overview. This is not a systematic review, endorsement or treatment recommendation.
- Thurston et al. (2022): Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder →Kisspeptin-54; 40 randomized, 32 completed both visits; neuroimaging endpoints and limits of clinical inference.
